Increased Expression of the Normal Cellular Isoform of Prion Protein in Inclusion‐Body Myositis, Inflammatory Myopathies and Denervation Atrophy
暂无分享,去创建一个
Salvatore Monaco | Gianluigi Zanusso | M. Tabaton | P. Tonin | M. Filosto | T. Cavallaro | Massimo Tabaton | G. Zanusso | S. Monaco | Giuliano Tomelleri | N. Rizzuto | G. Tomelleri | Gaetano Vattemi | S. Ferrari | G. Vattemi | Sergio Ferrari | Elisa Pecini | Tiziana Cavallaro | Massimiliano Filosto | Paola Tonin | Ettore Nardelli | Nicola Rizzuto | E. Nardelli | Elisa Pecini
[1] S. Tabrizi,et al. Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity , 2000, Neurology.
[2] H. Budka,et al. Evidence for Oxidative Stress in Experimental Prion Disease , 2000, Neurobiology of Disease.
[3] Hagen H. Kitzler,et al. Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis , 1999, The Lancet.
[4] S. Hornemann,et al. Prion protein expression in different species: analysis with a panel of new mAbs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[6] F. Cohen,et al. Prion Protein Biology , 1998, Cell.
[7] W. Engel,et al. Increase of nitric oxide synthases and nitrotyrosine in inclusion‐body myositis , 1996, Neuroreport.
[8] B. Imperiali,et al. Modulation of protein structure and function by asparagine-linked glycosylation. , 1996, Chemistry & biology.
[9] B. Imperiali,et al. Analysis of the conserved glycosylation site in the nicotinic acetylcholine receptor: potential roles in complex assembly. , 1995, Chemistry & biology.
[10] M. Beal,et al. Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.
[11] S. Prusiner,et al. Etiology and pathogenesis of prion diseases. , 1995, The American journal of pathology.
[12] W. Engel,et al. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. , 1994, The American journal of pathology.
[13] P. Gambetti,et al. Alzheimer's disease and prion proteins: a meeting made in muscle. , 1994, The American journal of pathology.
[14] S. Prusiner,et al. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins , 1994, Cell.
[15] W. Engel,et al. Prion protein is abnormally accumulated in inclusion‐body myositis , 1993, Neuroreport.
[16] N. Cashman,et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein , 1992, Neurology.
[17] John Collinge,et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.
[18] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[19] Neil R. Cashman,et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation , 1990, Cell.
[20] Jurg Ott,et al. Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.
[21] W. J. Brown,et al. Familial neurological disease associated with spongiform encephalopathy. , 1976, Archives of neurology.
[22] P. Daniel,et al. DEGENERATION OF THE CEREBELLAR AND HYPOTHALAMONEUROHYPOPHYSIAL SYSTEMS IN SHEEP WITH SCRAPIE; AND ITS RELATIONSHIP TO HUMAN SYSTEM DEGENERATIONS. , 1964, Brain : a journal of neurology.
[23] H. Kretzschmar,et al. Prion protein expression in muscle cells and toxicity of a prion protein fragment. , 1998, European journal of cell biology.
[24] F. Mastaglia,et al. Genetic Factors in Sporadic Inclusion-Body Myositis , 1998 .
[25] D. Bates,et al. The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis , 1997 .
[26] S. Prusiner,et al. Prion diseases and neurodegeneration. , 1994, Annual review of neuroscience.